Tuesday, September 1, 2009

BioPharmas Go Down Too

This sector continues its gut wrenching volatility with a couple of big drops in pre-market trading:

SQNM is down $0.39 in pre-market trading at $6.00 a share
ACAD is down 70% on news that testing for their Parkinson's Disease treatment did not go well


We also have a couple of large upside moves in the sector:

Novavax (NVAX) is up $0.96 at $7.00
Hemispherx (HEB) is up $0.10 at $2.32
Sinovac (SVA) up $1.24 at $10.86

No comments:

Post a Comment